NIMH is joining the National Institute on Drug Abuse (NIDA) during National Drug Facts Week for the eighth annual live online Drug Facts Chat Day. Students ask NIDA and NIMH experts about drugs, alcohol, and mental health.
NIH director Francis Collins, M.D., discusses some of the 58 projects funded in the first wave of grants awarded by the NIH under the BRAIN Initiative. He spoke at a press conference announcing the awards, September 30, 2014.
Carlos A. Zarate, M.D. is Chief, Section on the Neurobiology and Treatment of Mood Disorders and Chief of Experimental Therapeutics and Pathophysiology Branch (ETPB) at the National Institute of Mental Health, and Clinical Professor of Psychiatry and Behavioral Sciences, at The George Washington University.
Dr. Averbeck attained a B.S. in Electrical Engineering from the University of Minnesota in 1994. After working 3 years in industry, Dr. Averbeck returned to the University of Minnesota and completed a Ph.D. in Neuroscience in 2001, working in the lab of Dr. Apostolos Georgopoulos. His thesis was titled, "Neural Mechanisms of Copying Geometrical Shapes".
Dr. Baker is Chief of the Unit on Learning and Plasticity in the Laboratory of Brain and Cognition. He received his B.A. in Neuroscience in 1995 from the University of Cambridge in England, and his Ph.D. in Psychology in 1999 from the University of St. Andrews in Scotland, where he worked with Dr. David Perrett on neurophysiological studies of visual perception.